Page 758 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 758

References     3


                        (ALI)/acute respiratory distress syndrome (ARDS). Am J Respir     79. Ghezzi P, Dinarello CA, Bianchi M, et al. Hypoxia increases
                        Crit Care Med. 2004;169:A18.                              production of interleukin-1 and tumor necrosis factor by
                      62. Nuckton TJ, Alonso JA, Kallet RH, et al. Pulmonary dead-space   human mononuclear cells. Cytokine. 1991;3:189.
                        fraction as a risk factor for death in the acute respiratory distress     80. Dinarello CA. Biology of interleukin 1. FASEB J. 1988;2:108.
                        syndrome. N Engl J Med. 2002;346:1281.               81. Li XY, Donaldson K, Brown D, MacNee W. The role of tumor
                      63. Gattinoni L, Pelosi P, Suter PM. Acute respiratory distress   necrosis factor in increased airspace epithelial permeability in
                        syndrome caused by pulmonary and extrapulmonary disease.   acute lung inflammation. Am J Respir Cell Mol Biol. 1995;13:185.
                        Different syndromes? Am J Respir Crit Care Med. 1998;158:3.    82. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF mono-
                      64. Eisner  MD, Thompson T,  Hudson LD,  et al.  Efficacy of low   clonal antibodies prevent septic shock during lethal bacterae-
                        tidal volume ventilation in patients with different clinical risk   mia. Nature. 1987;330:662.
                        factors for acute lung injury and the acute respiratory distress     83. Beutler B, Cerami A. Cachectin: more than a tumor necrosis
                        syndrome. Am J Respir Crit Care Med. 2001;164:231.      factor. N Engl J Med. 1987;316:380.
                      65. Montgomery AB, Stager MA, Carrico CJ, et al. Causes of     84. Gamble JR, Harlan JM, Klebonoff SJ, Vados MA. Stimulation of
                          mortality in patients with the adult respiratory distress   the adherence of neutrophils to umbilical vein endothelium by
                          syndrome. Am J Respir Crit Care Med. 1985;132:485.    human recombinant tumor necrosis factor. Proc Natl Acad Sci
                      66. Bell RC, Coalson JJ, Smith JD, et al. Multiple organ system   USA. 1985;82:8667.
                          failure and infection in adult respiratory distress syndrome.     85. Pohlman TH, Stanness KA, Beatty PG, et al. An endothelial cell sur-
                        Ann Intern Med. 1983;99:293.                            face factor(s) induced in vitro by lipopolysaccharide, interleukin 1,
                      67. Herridge MS, Tansey CM, Matté A, et al. Functional disability   and tumor necrosis factor-alpha increases neutrophil adherence by
                        5 years after acute respiratory distress syndrome. N Engl J Med.   a CDw18-dependent mechanism. J Immunol. 1986;136:4548.
                        2011;364:1293.                                       86. Bevilacqua MP, Pober JS, Wheeler  ME, et al.  Interleukin-1
                      68. Adhikari NK, Tansey CM, McAndrews MP, et al. Self-reported     activation  of  vascular  endothelium.  Effects  on  procoagulant
                        depressive symptoms and memory complaints in survivors five   activity and leukocyte adhesion. Am J Pathol. 1985;121:394.
                        years after ARDS. Chest. 2011;140:1484.              87. Bauer TT, Monton C, Torres A, et al. Comparison of systemic
                      69. Hopkins RO, Weaver LK, Collingridge D, et al. Two-year   cytokine levels in patients with acute respiratory distress
                        cognitive, emotional,  and  quality-of-life  outcomes  in  acute     syndrome, severe pneumonia, and controls. Thorax. 2000;55:46.
                        respiratory distress syndrome.  Am J Respir Crit Care Med.     88. Parsons PE, Moore FA, Moore EE, et al. Studies on the role of
                        2005;171:340.                                           tumor necrosis factor in adult respiratory distress syndrome.
                      70. Bienvenu OJ, Colantuoni E, Mendez-Tellez PA, et al. Depressive   Am Rev Respir Dis. 1992;146:694.
                        symptoms and impaired physical function after acute lung     89. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor
                        injury: a 2-year longitudinal study. Am J Respir Crit Care Med.   necrosis factor levels in serum and bronchoalveolar lavage fluid
                        2012;185:517.                                           of patients with the adult respiratory distress syndrome. Am Rev
                      71. Tomashefski JF. Pulmonary pathology of acute respiratory dis-  Respir Dis. 1991;144:268.
                        tress syndrome. Clin Chest Med. 2000;21:435.         90. Millar AB, Foley NM, Singer M, et al. Tumour necrosis factor in
                      72. Tomashefski JF Jr. Pulmonary pathology of the acute respira-  bronchopulmonary secretions of patients with adult respiratory
                        tory distress syndrome. Diffuse alveolar damage. In: Ma M ed.   distress syndrome. Lancet. 1989;2:712.
                        Acute Respiratory Distress Syndrome. New York: Marcel Dekker;     91. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels
                        2003:75.                                                of tumor necrosis factor and its inhibitors, interleukin-1, inter-
                      73. Meduri  GU,  Belenchia  JM,  Estes  RJ,  et  al.  Fibroproliferative   feron, and elastase, in patients with adult respiratory distress
                        phase of ARDS: clinical findings and effects of corticosteroids.   syndrome after trauma, shock, or sepsis.  Am Rev Respir Dis.
                        Chest. 1991;100:943.                                    1992;145:1016.
                      74. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological     92. Meduri GU, Headley S, Kohler G, et al. Persistent elevation
                        markers  of  acute  lung  injury:  prognostic  and  pathogenetic   of inflammatory cytokines predicts a poor outcome in ARDS.
                          significance. Am J Respir Crit Care Med. 1997;155:1187.  Plasma IL-1 beta and IL-6 levels are consistent and efficient
                      75. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory   predictors of outcome over time. Chest. 1995;107:1062.
                        distress syndrome. J Clin Invest. 2012;122:2731.     93. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal  volume
                      76. Clark  JG,  Milberg  JA,  Steinberg  KP,  Hudson  LD. Type  III   ventilation and plasma cytokine markers of inflammation in
                                                                                patients with acute lung injury. Crit Care Med. 2005;33:1.
                          pro-collagen peptide in the adult respiratory distress syndrome.
                        Association of increased peptide levels in bronchoalveolar     94. Opitz B, van Laak V, Eitel J, Suttorp N. Innate immune recogni-
                        lavage fluid with increased risk for death [see comments]. Ann   tion in infectious and noninfectious diseases of the lung. Am J
                        Intern Med. 1995;122:17.                                Respir Crit Care Med. 2010;181:1294.
                      77. Tracey KJ, Lowry SF, Cerami A. Cachetin/TNF-alpha in septic     95. Dowling JK, O’Neill LA. Biochemical regulation of the inflam-
                        shock and septic adult respiratory distress syndrome. Am Rev   masome. Crit Rev Biochem Mol Biol. 2012;47:424.
                        Respir Dis. 1988;138:1377.                           96. Lamkanfi M. Emerging inflammasome effector mechanisms.
                      78. Goodman RB, Strieter RM, Martin DP, et al. Inflammatory   Nat Rev Immunol. 2011;11:213.
                        cytokines in patients with persistence of the acute respira-    97. Hornung  V, Bauernfeind  F,  Halle  A, et  al. Silica crystals  and
                        tory distress syndrome.  Am J Respir Crit Care Med. 1996;   aluminum salts activate the NALP3 inflammasome through
                        154:602.                                                phagasomal destabilization. Nat Immunol. 2008;9:847.









            Section04-O-ref.indd   3                                                                                   1/21/2015   11:23:17 AM
   753   754   755   756   757   758   759   760   761   762   763